• Home
  • Zennova Pharmaceuticals(Chengdu)Co.,Ltd
16-18
Jun
2026
CPHI & PMEC China 2026
Shanghai New International Expo Center
E6F61
Book a meeting
6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
10G68
Book a meeting

Zennova Pharmaceuticals(Chengdu)Co.,Ltd

About Zennova Pharmaceuticals(Chengdu)Co.,Ltd

Zennova Pharma Group is an innovation-driven multinational offering one‑stop CRDMO+S services—R&D, manufacturing, sales, and market management. With its complex formulation platform and FDA/EMA/China GMP‑compliant facilities, it accelerates the entire path from development to launch. Its proven overseas sales and operational capabilities support Chinese pharmaceuticals in reaching global markets, covering regulatory submissions, marketing authorization, logistics, and after‑sales support.

Read more Show less
Certifications
  • FDA
    FDA
More certifications Show less
Sales Markets
Show more Show less
Categories
more categories Show less

Meet us at

  • CPHI & PMEC China 2026

    CPHI & PMEC China 2026

    Shanghai New International Expo Center
    16 Jun 2026 - 18 Jun 2026
  • CPHI Milan 2026

    CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    China
  • Founded:
    2018
  • On CPHI since:
    2025
  • Certificates:
    1
  • Employees:
    50 - 99
Company types
Biopharmaceutical company
CMO/CDMO
Contract Research Organisation (CRO)
Distributor/Import Export
Generics/Biosimilars Manufacturer
Primary activities
Chemical Development
Contract Manufacturer
Contract Research Organisation
Pharmaceutical Company (generic finished products)
Contact info
  • 0354-6638277
  • Website
  • No. 617, Fenghuang Road,, Shuangliu District,, 610200, Chengdu, Sichuan, China
Show contact info Hide contact info

Products from Zennova Pharmaceuticals(Chengdu)Co.,Ltd (1)

  • Pramipexole Hydrochloride

    Product Pramipexole Hydrochloride

    Pramipexole dihydrochloride is a non-ergot dopamine agonist indicated for the treatment of:

    • Parkinson's disease (PD)

    Moderate-to-severe primary Restless Legs Syndrome (RLS)